Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg, (a) 500-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A. NDC 0378-6325-05.
Published December 19, 2018 · Recall initiated: November 20, 2018
Summary
FDA records drug Class II recall D-0317-2019, published December 19, 2018 and initiated November 20, 2018. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Ongoing; Reported quantity: 5,660 bottles; Lot: Lot # 3084886, exp. date 2/2019 Lot # 3093804, exp. date 12/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.
What to do
Voluntary: Firm initiated · Press Release
Get an email if VALSARTAN AND HYDROCHLOROTHIAZIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VALSARTAN AND HYDROCHLOROTHIAZIDE
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Product was distributed throughout the United States.
- UPC
- 0303786323777
- Lot
- Lot # 3084886, exp. date 2/2019 Lot # 3093804, exp. date 12/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAValsartan and Hydrochlorothiazide Tablets, USP 320/25 mg, (a) 90-count bottle (NDC 0378-6325-77), (b)December 19, 2018
- FDAValsartan and Hydrochlorothiazide Tablets, USP 160/25 mg, (a) 90-count bottle (NDC 0378-6323-77), (b)December 19, 2018
- FDAValsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg, (a) 90-count bottle (NDC 0378-6322-77), (b)December 19, 2018
- FDAValsartan and Hydrochlorothiazide Tablets, USP 80/12.5 mg, (a) 90-count bottle (NDC 0378-6321-77), (b)December 19, 2018
- FDAValsartan Tablets, USP, 320 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAAmlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30-count bottle, Rx Only, Made in India, ManufacturedDecember 19, 2018
Questions about this recall
Was Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg, (a) 500-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A. NDC 0378-6325-05. recalled?
Yes. FDA published recall D-0317-2019 on December 19, 2018. Reported hazard: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VALSARTAN AND HYDROCHLOROTHIAZIDE. UPC: 0303786323777.